Pear Therapeutics CEO Corey McCann, MD, PhD delves into the potential digital therapeutics have in helping people who abuse drugs and alcohol. The company’s product pipeline includes potential treatment for schizophrenia, combat-PTSD, generalized anxiety disorder, insomnia and traumatic brain injury.

How Pear Therapeutics is Creating Digital Therapeutics to Treat Substance Use Disorders

The Breaking Health Podcast features the innovators, investors and entrepreneurs who are building the technology and tools to break down and build up the country’s ailing health care system. With seasoned health care investor Steve Krupa, CEO of the Psilos Group, as host, Breaking Health delivers the earliest insights on the ongoing Digital Health Revolution.

Share How Pear Therapeutics is Creating Digital Therapeutics to Treat Substance Use Disorders

Sign up to save your podcasts

How Pear Therapeutics is Creating Digital Therapeutics to Treat Substance Use Disorders

How Pear Therapeutics is Creating Digital Therapeutics to Treat Substance Use Disorders

More shows like Breaking Health

WSJ Tech News Briefing

WSJ What’s News

Freakonomics Radio

The NPR Politics Podcast

How to Be Awesome at Your Job

The Daily

Up First from NPR

Conan O’Brien Needs A Friend

Morning Brew Daily

The Prof G Pod with Scott Galloway

All-In with Chamath, Jason, Sacks & Friedberg

Barron's Streetwise

People I (Mostly) Admire

The Rest Is History

The Ezra Klein Show